US$ 21.35
semaglutide statpearls Ozempic (semaglutide) is changing weight management by reducing appetite and improving blood sugar—but its rising popularity raises important questions about access, ethics, and who truly needs it. #ozempic #weightloss #diabetes #healthcare #fypシ Semaglutide: Double-edged Sword with Risks
Description
Semaglutide drugs like Ozempic help people lose weight since it is a type of GLP therapy

Wegovy tablets offer a needle-free oral GLP-1 option, using the same active ingredient and with comparable weight loss results to the Wegovy injection

Arnold SE, Arvanitakis Z, Macauley-Rambach SL, Koenig AM, Wang HY, Ahima RS, et al

In the pivotal SUSTAIN trials examining semaglutide for type 2 diabetes management, vomiting was reported in 5-9% of patients receiving therapeutic doses (0.5 mg or 1 mg weekly subcutaneous injections), compared to approximately 2-3% in placebo groups

Getting to know GLP-1 users, a new kind of consumer

Depress Anxiety
